Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 27.43 billion as of June 3, 2025. Its market cap has decreased by -3.32% in one year.

Market Cap

27.43B

Enterprise Value

26.19B

Revenue

43.59M

Ranking

n/a

PE Ratio

n/a

Stock Price

177.50

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 27.43B, an increase of 538.73%. That is a compound annual growth rate of 20.63%.

Market Cap History

Date	Market Cap	% Change
Jun 2, 2025	26.93B	-36.23%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	166.36B
Caliway Biopharmaceuticals	135.59B
Bora Pharmaceuticals Co., LTD.	79.47B
Lotus Pharmaceutical	61.48B
Polaris Group	31.97B
Center Laboratories	29.07B
Oneness Biotech	27.98B
Pegavision	26.60B

Market Cap Rankings